Don’t Go Home With a Loser on New Year’s
These companies reek of financial hangover. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
Make Money Even When Drugs Fail
Biotech growth potential without as much risk. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
Natural Gas Executives Cash In Their Chips
Can we divine the commodity’s future from these insider actions? From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
These Refiners Will Survive
Regional market differences are more important than ever before. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
5-Star Stocks on the Upswing
Check out these newly minted five-star stocks. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
4-Star Stocks on the Upswing
It can pay to catch rising stars. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
3 Stocks Hitting High Notes
These stocks are reaching for the stars. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
What’s the Best Recipe for Financial Regulatory Reform?
Experts give their insight on what’s ahead for the industry. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
2010 FDA Decisions to Watch
It’s a pivotal year for these drugmakers. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.
2 Very Different Visions of Our Energy Future
Take a break from the year-ahead forecasts to consider these multi-decade assessments. From Fool.com: The Motley Fool. Please read the complete article and let us know what you think below.

« Previous Entries